Literature DB >> 1382506

Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells.

A Pessina1, E Mineo, M G Neri, L Gribaldo, R Colombi, P Brambilla, G Zaleskis.   

Abstract

A new murine cell line designated as SR-4987 was established by treating a long-term bone marrow culture with the supernatant from Y-1 cells which actively produce viral C-particles (MuLV). The line showed a fibroblast-like morphology and its mesodermal origin was confirmed by immunocytochemical staining. Flow cytometric analysis of DNA index evidenced a tetraploid number of chromosomes whereas cell cycle analysis showed 34.8% of cells in S phase and 60.7% in G1. In vitro growth studies demonstrated a population doubling time of 14.7 h, a good plating efficiency (52.3%) and a very poor agar clonogenic capacity (0.6%). SR-4987 was tumorigenic only in syngeneic mice in which sarcomas were induced. The line produced M-CSF in the culture supernatant whereas G-CSF, IL-3 and GM-CSF were not detected. Studies are in progress to assess the production of other cytokines and to verify if same autocrine growth factor is involved in the control of SR-4987 proliferation. Our line provides a further model of stromal cells for studying the interaction between hemopoietic progenitors and their microenvironment, as well as to study factors produced by stromal cells acting as modulators of proliferation and differentiation of related cell populations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382506     DOI: 10.1007/bf02525491

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  29 in total

1.  Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone.

Authors:  J Ohmori; T Ezaki; M Kotani
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

Review 2.  ras oncogenes: their role in neoplasia.

Authors:  M Barbacid
Journal:  Eur J Clin Invest       Date:  1990-06       Impact factor: 4.686

3.  Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta.

Authors:  J D Cashman; A C Eaves; E W Raines; R Ross; C J Eaves
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

4.  Stromal cell-associated hematopoiesis: immortalization and characterization of a primate bone marrow-derived stromal cell line.

Authors:  S R Paul; Y C Yang; R E Donahue; S Goldring; D A Williams
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

5.  Modulation of EL-4 mouse lymphoma cell proliferation by macrophages and tumor related factors.

Authors:  A Pessina; P Brambilla; P Mocarelli
Journal:  Blut       Date:  1984-07

6.  A colorimetric liquid culture assay of a growth factor for primitive murine macrophage progenitor cells.

Authors:  A B Kriegler; T R Bradley; G S Hodgson; I K McNiece
Journal:  J Immunol Methods       Date:  1987-10-23       Impact factor: 2.303

7.  Production of colony stimulating factor by EL-4 lymphoma cells stimulated with phytohemoagglutinin.

Authors:  A Pessina; P Brambilla; M G Neri; P Mocarelli
Journal:  Int J Immunopharmacol       Date:  1985

8.  Control of hemopoiesis by a bone marrow stromal cell clone: lipopolysaccharide- and interleukin-1-inducible production of colony-stimulating factors.

Authors:  D Rennick; G Yang; L Gemmell; F Lee
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

9.  Generation of murine stromal cell lines supporting hematopoietic stem cell proliferation by use of recombinant retrovirus vectors encoding simian virus 40 large T antigen.

Authors:  D A Williams; M F Rosenblatt; D R Beier; R D Cone
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

10.  Effect of lipopolysaccharide on the production of colony-stimulating factors by the stromal cells in long-term bone marrow culture.

Authors:  S Y Wang; C Y Su; M L Hsu; L Y Chen; C H Tzeng; C K Ho
Journal:  Exp Hematol       Date:  1991-02       Impact factor: 3.084

View more
  3 in total

1.  Spatial development of the cultivation of a bone marrow stromal cell line in porous carriers.

Authors:  M Takagi; T Sasaki; T Yoshida
Journal:  Cytotechnology       Date:  1999-11       Impact factor: 2.058

2.  Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.

Authors:  Augusto Pessina; Arianna Bonomi; Valentina Coccè; Gloria Invernici; Stefania Navone; Loredana Cavicchini; Francesca Sisto; Maura Ferrari; Lucia Viganò; Alberta Locatelli; Emilio Ciusani; Graziella Cappelletti; Daniele Cartelli; Caruso Arnaldo; Eugenio Parati; Giovanni Marfia; Roberto Pallini; Maria Laura Falchetti; Giulio Alessandri
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

3.  Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.

Authors:  Simone Pacioni; Quintino Giorgio D'Alessandris; Stefano Giannetti; Liliana Morgante; Ivana De Pascalis; Valentina Coccè; Arianna Bonomi; Luisa Pascucci; Giulio Alessandri; Augusto Pessina; Maria Laura Falchetti; Roberto Pallini
Journal:  Stem Cell Res Ther       Date:  2015-10-06       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.